Shchepotin I B, Kolesnik O O, Lukashenko A V, Burlaka A A, Pryĭmak V V, Hanich O V
Klin Khir. 2014 Nov(11):8-13.
In up to 50% of patients, suffering colorectal cancer (CRC), a hepatic metastatic affection was revealed, in 20-34% of them the metastases have occurred synchroniously with primary tumor. The main problem in estimation of resectability of metastatic CRC (mCRC) is a possibility to preserve a sufficient volume of the organ parenchyma, because an acute hepatic insufficiency (AHI) constitute one of the main risk factors for occurrence of complications and mortality in early postoperative period after extended hemihepatectomy. The expediency of application in National Cancer Institute of the insitu hepatic split in conjunction with a portal ligation (ISHS-PL), elaborated by surgical group in Regensburg, was studied up. The results of treatment of mCRC, using ISHS-PL--in 3 patients and of a standard two-staged hepatic resection--in 3, were analyzed. Duration of a gap period between the ISHS-PL stages have constituted on average (10 +/- 1) days, and for a standard two-staged hepatic resection--(56 +/- 11.3) days (p = 0.001). The investigation results witness a safety of performance of the ISHS-PL in patients, suffering mCRC. Application of such a surgical tactics have permitted to reduce the risk of an AHI occurrence after performance of the extended hepatic resection in patients, suffering bilobar metastatic hepatic affection.
在高达50%的结直肠癌(CRC)患者中发现有肝转移,其中20%-34%的患者转移灶与原发肿瘤同时出现。评估转移性结直肠癌(mCRC)可切除性的主要问题在于能否保留足够的肝实质体积,因为急性肝衰竭(AHI)是扩大半肝切除术后早期并发症和死亡的主要危险因素之一。对由雷根斯堡外科团队提出的原位肝劈离联合门静脉结扎术(ISHS-PL)在国立癌症研究所应用的可行性进行了研究。分析了3例采用ISHS-PL治疗mCRC患者和3例采用标准两阶段肝切除术患者的治疗结果。ISHS-PL各阶段之间的间隔期平均为(10±1)天,标准两阶段肝切除术的间隔期为(56±11.3)天(p = 0.001)。研究结果证明了ISHS-PL应用于mCRC患者的安全性。这种手术策略的应用降低了患有双叶转移性肝病变患者进行扩大肝切除术后发生AHI的风险。